Sentences with phrase «pharma inc.»

Acted for the monitor in the CCAA proceedings commenced by PanGeo Pharma Inc., a publicly traded pharmaceutical company.

With close to 30 years of proven results, I - MED Animal Health, a division of I - MED Pharma Inc., dedicates itself to improving the ocular health of companion animals by delivering the highest quality veterinary OSD, OVD, Diagnostic and Surgical product offering on the market.

Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.

Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals.

Davis is a consultant to and holds stock in Cerulean Pharma Inc..

Dr. Iwai is Divisional Senior Vice President of Candidate Discovery Science Labs., Drug Discovery Research, Astellas Pharma Inc..

The research was supported by grants from the National Cancer Institute and the National Institutes of Health and by Cerulean Pharma Inc..

Drug Discovery Research Astellas Pharma Inc..

In a new study in collaboration with Astellas Pharma Inc., the research team led by Osafune showed a circumventive solution.

During an event in Manchester, New Hampshire, on Monday, President Donald Trump asked a top executive from Adapt Pharma Inc. to join him on stage and handed him the microphone to talk about the company's programs that provide free and discounted samples of its Narcan spray to schools and first responders.

At an FDA advisory panel meeting in October 2016 to discuss appropriate naloxone dosing, Seamus Mulligan, chief executive of Adapt Pharma Inc., said that «lower doses of naloxone may deliver too little naloxone, too late.»

Cytokinetics is collaborating with Astellas Pharma Inc. («Astellas») to develop reldesemtiv (CK - 2127107), a next - generation fast skeletal muscle troponin activator (FSTA).

CAMBRIDGE, Mass. --(BUSINESS WIRE)-- Acceleron Pharma Inc. (NASDAQ: XLRN) today announced it will host a webcast and conference call on Tuesday, May 8, 2018 at 5:00 p.m. EDT to discuss its first quarter 2018 operating and financial results.

Acceleron Pharma Inc..

Not exact matches

In B.C. especially, companies such as QLT Inc., Angiotech Pharmaceuticals and Cardiome Pharma Corp. saw their valuations soar in the early 2000s, only to come crashing to earth by the end of the decade as a result of competitive pressures, regulatory snags, strategic blunders and deals gone awry.

Prior to joining Celgene, he was director, investor relations at MGI PHARMA, Inc..

He also is a director and non-executive Chairman of Mayne Pharma Group Limited, an Australian specialty pharmaceutical company (which recently purchased Metrics, Inc., a pharmaceutical company in North Carolina), and a former member of the Prime Minister's Community Business Partnership.

YESCARTA, the YESCARTA Logo, KITE KONNECT, KITE, and the KITE Logo are trademarks of Kite Pharma, Inc..

KITE KONNECT, KITE, and the KITE Logo are trademarks of Kite Pharma, Inc..

Holdings in the Global Resources Fund and Emerging Europe Fund as a percentage of net assets as of 9/30/2014: Berkshire Hathaway 0.00 %, Cubist Pharma 0.00 %, Market Vectors Russia ETF 0.00 %, Merck & Co., Inc. 0.00 %.

On Monday, United Therapeutics reached a deal to acquire Israel - based SteadyMed Therapeutics Inc. in a deal potentially valued at US$ 216mln, a move that eliminates a serious competitive threat to the Maryland biotech by literally pulling the speciality pharma company into its own corner.

Companies namely, Kerry Group plc, Associated British Foods plc, Roquette Fréres S.A., DuPont, Ingredion Incorporated, Meggle AG, Hilmar Ingredients, JRS Pharma GmbH & Co.KG, Innophos, Inc., Cargill, Incorporated and IMCD Group B.V. are observed as the global leaders in nutraceutical excipients production.

The so - called «Pharma Bro,» notorious for raising the price of a potentially life - saving drug by 5,000 percent, was found guilty today of defrauding investors in two hedge funds and in Retrophin Inc., a pharmaceutical company he co-founded.

They started in 2003 with legal action against Purdue Pharma LLP and Abbott Laboratories, Inc., for damages suffered by more than 5,000 clients prescribed the opioid OxyContin.

Spencer said two counties in California and the City of Chicago have filed similar lawsuits in Federal court against drug companies Purdue Pharma L.P., The Purdue Frederick Company, Teva Pharmaceutical Industries LTD., Cephalon Inc., Johnson and Johnson, Janssen Pharmaceuticals, Endo Health Solutions Inc., and Actavis PLC..

«Simply put, the compound turns - off the sperm's ability to swim, significantly limiting fertilization capabilities,» said lead investigator Michael O'Rand, PhD, retired professor of cell biology and physiology in the University of North Carolina at Chapel Hill School of Medicine, and president / CEO of Eppin Pharma, Inc. «This makes EP055 an ideal candidate for non-hormonal male contraception.»

Sengupta later co-founded Cerulean Pharma, Inc., which focuses on nanotechnology - based treatments.

They have joined forces with CHS Pharma, Inc., a South Florida - based biotechnology development company that has an intellectual property portfolio for potential treatments related to ischemic stroke, dry macular degeneration as well as other age - related disorders such as Alzheimer's disease, to further develop and commercialize this promising technology.

Keynote Address Akihiko Iwai, PhD Vice President, Astellas Pharma, Inc.; Vice Chairman, Forum for Innovative Regenerative Medicine (FIRM)

From 1997 - 2008, Joern was President and CEO of Evotec AG, where he designed many alliances with leading pharma and biotech companies, listed the Company on the Frankfurt Stock Exchange and NASDAQ, and managed the acquisition of LSE - listed Oxford Asymmetry and NASDAQ - listed Renovis Inc..

Astellas Pharma US, Inc. manufactures tacrolimis, which was used in this study.

These current and former employees of TransTech Pharma, Inc., and TransTech Pharma, LLC may own units or unit options in TransTech Pharma, LLC and / or High Point Pharmaceuticals, LLC.

The following authors are current or former employees of TransTech Pharma, Inc. or TransTech Pharma, LLC: OA, JK, SG, SV, MG, ZZ, DP, RA, AM, and MK.

TransTech Pharma, Inc., TransTech Pharma, LLC, and High Point Pharmaceuticals, LLC are affiliates.

Prior to Kadmon, Dr. Waksal served as Executive Vice President, Business and Scientific Affairs at Acasti Pharma, Inc., a publicly traded biopharmaceutical company, and as a consultant to Neptune Technologies & Bioressources, Inc., a publicly traded life sciences company and the parent company of Acasti.

Malloy's corporate support came from political action committees including, Aetna, Alcoa, Alexion, American Medical Response, AQN, AT&T, Bank of America, Boehringer Ingelheim, CBS, Cerner Corporation, Cigna, Comcast, Computer Sciences Corporation, Covanta Energy, Dominion Energy, Enterprise Holding, FoxPAC (Yes, related to the Fox News Corp.), General Dynamics, General Electric, GHC Corporation, Guardian, Hartford Financial, HNTB Holdings, Maximus, Minerals Technologies Inc., National Association of Chain Drug Stores, Northeast Utilities, Pfizer, Pitney Bowes, Praxair, Public Service of New Jersey, Purdue Pharma, Reinsurance Association of America, Safelite, Spectra Energy, Synergy, Nestle Waters, The Phoenix, The Travelers, Walt Disney Productions, Thermo Fischer Scientific, UnitedHealth, Wal - Mart, Walgreens, Webster Bank, Wellpoint, Xerox and the list goes on.

Acceleron Pharma, Inc. is a clinical stage biopharmaceutical company.

Henry Schein, Inc. (Nasdaq: HSIC) today announced that it has been named «Best Animal Healthcare Product Provider 2016» by Global Health & Pharma (GHP) Magazine, a UK - based health care publication, in its inaugural animal health awards.

MENOMONIE, Wis. (January 31, 2017)-- Noble Pharma, LLC, A Vets Plus Inc. company, announces groundbreaking for construction of a new pharmaceutical manufacturing facility.

Accutane ® is a registered trademark of Hoffman - La Roche, Inc.; Oxycontin ® is a registered trademark of Purdue Pharma, L.P.

Galenica Group recently announced that it has entered into a definitive agreement to acquire the US company Relypsa, Inc., (NASDAQ: RLYP), further strengthening its Business unit Vifor Pharma by gaining full global rights to the potassium binder Veltassa ® (patiromer) for oral suspension and...

Notable mandates: advised Apotex Holdings Inc. in its sale of all of the shares of Accucaps Industries Limited to Catalent Pharma Solutions; acted for Canada Goose in negotiating the terms of the company's lease for its first standalone retail store in Yorkdale Shopping Centre and for certain of its shareholders in connection with its IPO; represented Spin Master in connection with its $ 510 - million credit facility and various acquisitions; advised the management of LABORIE in the company's sale to Patricia Industries (a division of Investor AB) by Audax Private Equity; acted for NAFTA Foods and Create - a-Treat and their management in the sale of NAFTA CAT to Give and Go Prepared Foods Corp..

Galenica Group recently announced that it has entered into a definitive agreement to acquire the US company Relypsa, Inc., (NASDAQ: RLYP), further strengthening its Business unit Vifor Pharma by gaining full global rights to the potassium binder Veltassa ® (patiromer) for oral suspension and enhancing its growing position as a global specialty pharmaceutical company.

Inc., Bionest Partners, Leerink Partners, MLV & Co., Canaccord Genuity, GUGGENHEIM PARTNERS, CBPartners, Global Pharma, Pfizer, GuidePoint Global, Healthcare Group, A.T. Kearney, Accenture, Bain & Company, Bioinformatics LLC, Booz & Company, Booz Allen Hamilton, Boston Consulting Group, Deloitte, IMS Consulting Group, L.E.K. Consulting, McKinsey & Company, Monitor Group, Oliver Wyman, Opera Solutions, PricewaterhouseCoopers, Thomson Reuters, ZS Associates

Ideal Companies: Any Pharmaceutical, Bio therapeutic, Medical Corporation:, Abbott, Acredo, Acorda, Allergan, Amgen, Amylin, Aptalis, Astellas, Astra Zeneca, Avanir, Aventis, Baxter, Bayer, Becton Dickinson, Biogen Idec, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Centrix, Covidien, CSL Behring, Daichii Sankyo, Dainippon Sumitomo, Eisai, Eli Lilly, Endo Pharma, Ferring Pharma, Forest Laboratories, General Electric, Genentech, Genzyme, Glaxo Smith Kline, Hoffman - LaRoche, Hospira, InVentiv Health, Ironwood Pharma, Johnson & Johnson, Medicis Pharma, Medimmune, MedIsolv, Merck, Medtronic, Mylan Inc., Norgenix, Novis Pharma, Novo Nordisk, OctaPharma, Onyx Pharma, Ortho - McNeil, Otsuka Pharma, PDI, PDL BioPharma, Pfizer, Proctor & Gamble, Publicis, Purdue Pharma, Purepac Pharma, Quest Diagnostics, Lab Corps, Quintiles, Ranbaxy Pharma, Regeneron Pharma, Respa Pharma, Roche Phaarma, Royalty Pharma, Cypress Bioscience, Salix Pharma, Sanofi - Aventis, Savient Pharma, Shire Pharma, Sigfreid USA, Spectrum Pharma, Stryker Corp, Sunovion Pharma, Takeda Pharma, Teva Pharma, UCB Pharma, United Therapeutics, Zoetis Animal Pharma, 3M Pharma, Actavis Pharma, Indeva Pharma, Sunageva BioPharma, Dupont, plus any!